Gene variants of unknown clinical significance in Lynch syndrome. An introduction for clinicians

Familial Cancer

Volumn 12, Issue 2, 2013, Pages 181-187

  Sijmons, Rolf H ^a   Greenblatt, Marc S ^b   Genuardi, Maurizio ^c,d,e  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF FLORENCE   (Italy)

^d Fiorgen Foundation for Pharmacogenomics   (Italy)

^e ISTITUTO TOSCANO TUMORI   (Italy)

Author keywords

Classification; HNPCC; Lynch syndrome; Mismatch repair gene; Missense mutations; Pathogenicity; Variants

Indexed keywords

MISMATCH REPAIR PROTEIN;

ARTICLE; CLINICAL GENETICS; GENETIC CODE; GENETIC SCREENING; GENETIC VARIABILITY; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; MOLECULAR GENETICS; PRIORITY JOURNAL;

COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MISMATCH REPAIR; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENETIC VARIATION; HUMANS;

EID: 84880920383     PISSN: 13899600     EISSN: 15737292     Source Type: Journal    
DOI: 10.1007/s10689-013-9629-8     Document Type: Article

References (21)

1. Boland CR, Goel A (2010) Microsatellite instability in colorectal cancer. Gastroenterology 138(6):2073.e3-2073.e2087
2. Hampel H, Frankel WL, Martin E et al (2005) Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352(18):1851-1860
3. Pino MS, Chung DC (2010) Application of molecular diagnostics for the detection of Lynch syndrome. Expert Rev Mol Diagn 10(5):651-665 Review
4. Goldgar DE, Easton DF, Byrnes GB, Spurdle AB, Iversen ES, Greenblatt MS, IARC Unclassified Genetic Variants Working Group (2008) Genetic evidence and integration of various data sources for classifying uncertain variants into a single model. Hum Mutat 29(11):1265-1272
5. Heinen CD, Juel Rasmussen L (2012) Determining the functional significance of mismatch repair gene missense variants using biochemical and cellular assays. Hered Cancer Clin Pract 10(1):9
6. Rasmussen LJ, Heinen CD, Royer-Pokora B, Drost M, Tavtigian S, Hofstra RM, de Wind N (2012) Pathological assessment of mismatch repair gene variants in Lynch syndrome: Past, present, and future. Hum Mutat. Jul 25 doi: 10.1002/humu.22168
7. Parsons MT, Buchanan DD, Thompson B, Young JP, Spurdle AB (2012) Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification. J Med Genet 49(3):151-157
8. Niessen RC, Berends MJ, Wu Y, Sijmons RH et al (2006) Identification of mismatch repair gene mutations in young patients with colorectal cancer and in patients with multiple tumours associated with hereditary non-polyposis colorectal cancer. Gut 55(12):1781-1788
9. Gylling AH, Nieminen TT, Abdel-Rahman WM, Nuorva K, Juhola M, Joensuu EI, Järvinen HJ, Mecklin JP, Aarnio M, Peltomäki PT (2008) Differential cancer predisposition in Lynch syndrome: insights from molecular analysis of brain and urinary tract tumors. Carcinogenesis 29(7):1351-1359
10. Tuupanen S, Karhu A, Järvinen H, Mecklin JP, Launonen V, Aaltonen LA (2007) No evidence for dual role of loss of heterozygosity in hereditary non-polyposis colorectal cancer. Oncogene 26(17):2513-2517
11. Grantham R (1974) Amino acid difference formula to help explain protein evolution. Science 185(4154):862-864
12. Thompson BA, Greenblatt MS, Vallee MP et al (2012). Calibration of multiple in silico tools for predicting pathogenicity of mismatch repair gene missense substitutions. Hum Mutat Sep 4. doi: 10.1002/humu.22214
13. Wimmer K, Etzler J (2008) Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg? Hum Genet 124(2):105-122
14. Easton DF, Deffenbaugh AM, Pruss D, Frye C, Wenstrup RJ, Allen-Brady K, Tavtigian SV, Monteiro AN, Iversen ES, Couch FJ, Goldgar DE (2007) A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. Am J Hum Genet 81(5):873-883
15. Senter L, Clendenning M, Sotamaa K, Hampel H et al (2008) The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology 135(2):419-428
16. Bonadona V, Bonaïti B, Olschwang S et al (2011) Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA 305(22):2304-2310
17. Ou J, Niessen RC, Lützen A, Sijmons RH, Kleibeuker JH, de Wind N, Rasmussen LJ, Hofstra RM (2007) Functional analysis helps to clarify the clinical importance of unclassified variants in DNA mismatch repair genes. Hum Mutat 28(11):1047-1054
18. Couch FJ, Rasmussen LJ, Hofstra R, Monteiro AN, Greenblatt MS, de Wind N, IARC Unclassified Genetic Variants Working Group (2008) Assessment of functional effects of unclassified genetic variants. Hum Mutat 29(11):1314-1326
19. Thompson BA, Goldgar DE, Paterson C, Clendenning M et al (2012). A multifactorial likelihood model for MMR gene variant classification incorporating probabilities based on sequence bioinformatics and tumor characteristics: A report from the colon cancer family registry. Hum Mutat Sep 4. doi: 10.1002/humu.22213
20. Lindor NM, Guidugli L, Wang X, Vallée MP, Monteiro AN, Tavtigian S, Goldgar DE, Couch FJ (2012) A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS). Hum Mutat 33(1):8-21
21. Plon SE, Eccles DM, Easton D, Foulkes WD, Genuardi M, Greenblatt MS, Hogervorst FB, Hoogerbrugge N, Spurdle AB, Tavtigian SV, IARC Unclassified Genetic Variants Working Group (2008) Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat 29(11):1282-1291